Janux Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC JANX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

75,498

Value ($000)

1,042

Weight

0.0%

2024 Q1 - 2025 Q4 (8 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,042	0.0%	75,498	12/31/2025
2025 Q3	11/14/2025	1,621	0.0%	66,325	9/30/2025
2025 Q2	8/14/2025	2,572	0.0%	111,362	6/30/2025
2025 Q1	5/19/2025	5,033	0.0%	186,394	3/31/2025
2024 Q4	2/14/2025	8,874	0.0%	165,737	12/31/2024
2024 Q3	11/14/2024	1,190	0.0%	26,194	9/30/2024
2024 Q2	8/14/2024	1,264	0.0%	30,178	6/30/2024
2024 Q1	5/15/2024	327	0.0%	8,695	3/31/2024